Linganisha mbinu
Pitia mbinu ulizochagua bega kwa bega; safu zinazotofautiana zinaangaziwa.
| Kiwango cha Tathmini ya Ukali wa Kujiua cha Columbia (C-SSRS)× | Orodha ya Haraka ya Dalili za Huzuni (QIDS)× | |
|---|---|---|
| Nyanja | Saikolojia ya Kliniki | Saikolojia ya Kliniki |
| Familia | Process / pipeline | Process / pipeline |
| Mwaka wa asili≠ | 2008 | 2003 |
| Mwanzilishi≠ | Kelly Posner | A. John Rush |
| Aina≠ | Clinician-administered interview scale | Self-report or clinician-administered questionnaire |
| Chanzo asilia≠ | Posner, K., Brown, G. K., Stanley, B., Brent, D. A., Yershova, K. V., Oquendo, M. A., & Shen, S. (2011). The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. American Journal of Psychiatry, 168(12), 1266–1277. DOI ↗ | Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., & Ninan, P. T. (2003). The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biological Psychiatry, 54(5), 573–583. DOI ↗ |
| Majina mbadala≠ | C-SSRS, Columbia Suicide Severity Rating Scale | QIDS, Quick Inventory of Depressive Symptomatology-Self Report, QIDS-SR |
| Zinazohusiana | 4 | 4 |
| Muhtasari≠ | The Columbia-Suicide Severity Rating Scale is a brief clinician-administered assessment of suicide risk developed by Kelly Posner and colleagues at Columbia University to address limitations in prior screening tools. First published in the American Journal of Psychiatry in 2011, the C-SSRS has become the FDA-endorsed standard for monitoring suicidal ideation and behavior in antidepressant, anticonvulsant, and neuropsychiatric medication trials. The scale assesses both suicidal ideation (frequency and intensity) and suicidal behavior (attempts, preparatory acts) over defined time windows, providing structured risk stratification. | The Quick Inventory of Depressive Symptomatology is a 16-item assessment designed by A. John Rush and colleagues to efficiently measure the severity of depressive symptoms in adults. Published in Biological Psychiatry in 2003, the QIDS exists in both self-report (QIDS-SR) and clinician-rated (QIDS-C) versions. It was developed as a brief alternative to the longer Inventory of Depressive Symptomatology (IDS, 30 items) while maintaining comprehensive coverage of DSM-IV depressive symptoms. The QIDS has become a standard outcome measure in treatment research, particularly in large comparative effectiveness trials. |
| ScholarGateSeti ya data ↗ |
|
|